LINC01016 and endometrial cancer: To explore whether LINC01016 could function as a ceRNA for NFYA by modulating miR-302a-3p/miR-3130-3p in endometrial cancer, NFYA and SATB1 levels were measured by qRT-PCR and western blot in cells transfected with LINC01016 (+), LINC01016 (−), agomir-302a-3p/miR-3130-3p, or antagomir-302a-3p/miR-3130-3p.